Streetbeat News

Products Services

CLMB

Climb Channel Solutions, a subsidiary of Climb Global Solutions, has added A-LIGN, a leading security vendor in compliance, to its global offerings. This move could enhance Climb's market position in the security and compliance sector.

Portfolio Pulse from Benzinga Newsdesk

September 25, 2024 | 11:05 am

KYMR

Kymera Therapeutics has presented preclinical data for KT-621, targeting TH2-driven allergic and atopic diseases. The company plans to start a Phase 1 trial in the second half of 2024, with results expected in the first half of 2025.

Portfolio Pulse from Benzinga Newsdesk

September 25, 2024 | 11:03 am

ALTR

Altair is participating in a £5.8M project focused on Performance Integrated Vehicle Optimization Technology, supported by Innovate UK and the Advanced Propulsion Centre.

Portfolio Pulse from Benzinga Newsdesk

September 25, 2024 | 11:02 am

STKH

Steakholder Foods has entered into a sales agreement with Bondor Foods Ltd. to supply its proprietary plant-based premixes for producing white fish and salmon patties.

Portfolio Pulse from Benzinga Newsdesk

September 25, 2024 | 11:01 am

APA

PLTR

Palantir and APA have extended their enterprise agreement, originally signed in 2021, for multiple years and millions of dollars. This extension introduces new AI capabilities using Palantir's AIP software across APA's global portfolio.

Portfolio Pulse from Benzinga Newsdesk

September 25, 2024 | 11:00 am

FXI

China plans to address the impact of AI and expand employment opportunities for youth, including college graduates. This initiative may influence sectors related to technology and education.

Portfolio Pulse from Benzinga Newsdesk

September 25, 2024 | 10:57 am

META

MU

NVDA

QQQ

SPY

US stocks may face some weakness as traders position defensively ahead of key events. Micron's earnings and Meta's event are in focus. The S&P 500 hit record highs, and analysts are optimistic about Q4. Major indices showed mixed performance, with Nvidia boosting tech stocks.

Portfolio Pulse from Shanthi Rexaline

September 25, 2024 | 10:52 am

LLY

Eli Lilly's Ebglyss treatment for moderate-to-severe atopic dermatitis shows promising long-term results. Over 80% of patients who responded at week 16 maintained skin clearance for up to three years with monthly maintenance dosing.

Portfolio Pulse from Benzinga Newsdesk

September 25, 2024 | 10:48 am

AVGO

IWF

XLK

FS has announced new 400G and 800G Ethernet switches powered by Broadcom's Tomahawk 5 chipset, targeting AI, big data, and HPC applications. Broadcom's AI business is expected to grow significantly, with a projected CAGR of 30%-40% over the next few years. Broadcom's stock has risen 110% in the past year, and investors can gain exposure through ETFs like XLK and IWF.

Portfolio Pulse from Anusuya Lahiri

September 25, 2024 | 10:47 am

MRK

Merck announced that its Phase 3 KEYFORM-007 trial, testing a fixed-dose combination of Favezelimab and Keytruda (Pembrolizumab), did not meet the primary endpoint of overall survival in patients with previously treated PD-L1 positive microsatellite stable metastatic colorectal cancer.

Portfolio Pulse from Benzinga Newsdesk

September 25, 2024 | 10:47 am